Literature DB >> 23325419

An overview of the highly pathogenic H5N1 influenza virus.

Jingchuan Yin1, Shi Liu, Ying Zhu.   

Abstract

Since the first human case of H5N1 avian influenza virus infection was reported in 1997, this highly pathogenic virus has infected hundreds of people around the world and resulted in many deaths. The ability of H5N1 to cross species boundaries, and the presence of polymorphisms that enhance virulence, present challenges to developing clear strategies to prevent the pandemic spread of this highly pathogenic avian influenza (HPAI) virus. This review summarizes the current understanding of, and recent research on, the avian influenza H5N1 virus, including transmission, virulence, pathogenesis, clinical characteristics, treatment and prevention.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325419      PMCID: PMC7090813          DOI: 10.1007/s12250-013-3294-9

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  145 in total

Review 1.  Prevention and treatment of influenza.

Authors:  R B Couch
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  Characteristics of stork feces-derived H5N1 viruses that are preferentially transmitted to primary human airway epithelial cells.

Authors:  Ampa Suksatu; Wichayapong Sangsawad; Arunee Thitithanyanont; Nat Smittipat; Mark M Fukuda; Sukathida Ubol
Journal:  Microbiol Immunol       Date:  2009-12       Impact factor: 1.955

4.  Analysis of cytokine secretion from human plasmacytoid dendritic cells infected with H5N1 or low-pathogenicity influenza viruses.

Authors:  Matthew R Sandbulte; Adrianus C M Boon; Richard J Webby; Janice M Riberdy
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

Review 5.  The evolution of epidemic influenza.

Authors:  Martha I Nelson; Edward C Holmes
Journal:  Nat Rev Genet       Date:  2007-01-30       Impact factor: 53.242

6.  Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection.

Authors:  Wei Li; Fang Yang; Yan Liu; Rui Gong; Li Liu; Yong Feng; Pan Hu; Wei Sun; Qian Hao; Lei Kang; Jianguo Wu; Ying Zhu
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

Review 7.  Innate immune responses to influenza A H5N1: friend or foe?

Authors:  Joseph Sriyal Malik Peiris; Chung Yan Cheung; Connie Yin Hung Leung; John Malcolm Nicholls
Journal:  Trends Immunol       Date:  2009-10-26       Impact factor: 16.687

8.  Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.

Authors:  Mary A Hoelscher; Sanjay Garg; Dinesh S Bangari; Jessica A Belser; Xiuhua Lu; Iain Stephenson; Rick A Bright; Jacqueline M Katz; Suresh K Mittal; Suryaprakash Sambhara
Journal:  Lancet       Date:  2006-02-11       Impact factor: 79.321

9.  Highly pathogenic avian influenza virus H5N1 infection in a long-distance migrant shorebird under migratory and non-migratory states.

Authors:  Leslie A Reperant; Marco W G van de Bildt; Geert van Amerongen; Debbie M Buehler; Albert D M E Osterhaus; Susi Jenni-Eiermann; Theunis Piersma; Thijs Kuiken
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

10.  Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.

Authors:  Suki M Y Lee; Jennifer L Gardy; C Y Cheung; Timothy K W Cheung; Kenrie P Y Hui; Nancy Y Ip; Y Guan; Robert E W Hancock; J S Malik Peiris
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more
  7 in total

1.  Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses.

Authors:  Qing Wang; Xueyuan Chen; Jian Feng; Yanhua Cao; Yu Song; Hui Wang; Chengliang Zhu; Shi Liu; Ying Zhu
Journal:  J Virol       Date:  2013-08-14       Impact factor: 5.103

2.  Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2.

Authors:  Peiyang Ding; Qianyue Jin; Xinxin Chen; Suzhen Yang; Junqing Guo; Guangxu Xing; Ruiguang Deng; Aiping Wang; Gaiping Zhang
Journal:  Int J Nanomedicine       Date:  2019-09-16

Review 3.  Populations at risk for severe or complicated Avian Influenza H5N1: a systematic review and meta-analysis.

Authors:  Dominik Mertz; Tae Hyong Kim; Jennie Johnstone; Po-Po Lam; Michelle Science; Stefan P Kuster; Shaza A Fadel; Dat Tran; Eduardo Fernandez; Neera Bhatnagar; Mark Loeb
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

4.  Dual Detection of Hemagglutinin Proteins of H5N1 and H1N1 Influenza Viruses Based on FRET Combined With DNase I.

Authors:  Zhiyun Wang; Qiuzi Zhao; Mengqian Huang; Yuqin Duan; Feifei Li; Tao Wang
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

Review 5.  Characteristics of human infection with avian influenza viruses and development of new antiviral agents.

Authors:  Qiang Liu; Dong-Ying Liu; Zhan-Qiu Yang
Journal:  Acta Pharmacol Sin       Date:  2013-10       Impact factor: 6.150

6.  Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets.

Authors:  Marco Goeijenbier; Eric C M van Gorp; Judith M A Van den Brand; Koert Stittelaar; Kamran Bakhtiari; Joris J T H Roelofs; Geert van Amerongen; Thijs Kuiken; Byron E E Martina; Joost C M Meijers; Albert D M E Osterhaus
Journal:  BMC Microbiol       Date:  2014-05-30       Impact factor: 3.605

7.  Enhanced protective efficacy of H5 subtype influenza vaccine with modification of the multibasic cleavage site of hemagglutinin in retroviral pseudotypes.

Authors:  Ling Tao; Jianjun Chen; Jin Meng; Yao Chen; Hongxia Li; Yan Liu; Zhenhua Zheng; Hanzhong Wang
Journal:  Virol Sin       Date:  2013-05-10       Impact factor: 4.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.